Focused on IVD
Driving Development With Technological Innovation

Led by Ph.D. experts from China and abroad, Shanghai Reigncom Biotech centers its strategy on R&D innovation, with a strong commitment to the in-vitro diagnostics (IVD) field. We were among the first in China to establish a clinical mass spectrometry platform and actively promote comprehensive precision diagnostic solutions. Our pioneering “pre-prepared kit” model for clinical mass spectrometry, combined with our advanced capabilities in developing protein macromolecule detection reagents, has enabled us to deliver multiple first-in-China or globally exclusive products. We are continually expanding our offerings in high-end manufacturing, precision testing, early screening and diagnosis, and laboratory quality assurance—contributing to the advancement of Chinese healthcare industry.